Skip to main content

BFSG, LLC

SEC CIK
0001706836
Latest filing
Jul 20, 2026

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by BFSG, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overviewAll 13F holders of KROSFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of KROS by BFSG, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−200−100.0%Sold outHolders
Q4 2023200$7.95K<0.1%+200NewHolders